Thrivent Financial for Lutherans
OLMA icon

Thrivent Financial for Lutherans’s Olema Pharmaceuticals OLMA Stock Holding History

Thrivent Financial for Lutherans’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-72,455
Closed -$308K – 2543
2025
Q2 		$308K Buy
+72,455
New +$323K ﹤0.01% 2298

Other funds holding OLMA

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Thrivent Financial for Lutherans's OLMA Position: Q3 2025 in Review

Thrivent Financial for Lutherans sold out of Olema Pharmaceuticals (OLMA) in Q3 2025, closing a stake of 72,455 shares — an estimated $308K sold.

Thrivent Financial for Lutherans first reported a position in OLMA in Q2 2025 and held it in 1 quarter. The position peaked at $308K in Q2 2025. 126 funds tracked by Wall St. Rank hold OLMA as of Q3 2025.

  • Thrivent Financial for Lutherans reported no remaining Olema Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 72,455 Olema Pharmaceuticals shares in Q3 2025, an estimated $308K.
  • Thrivent Financial for Lutherans first reported a position in Olema Pharmaceuticals in Q2 2025 and held it in 1 quarter.
  • Thrivent Financial for Lutherans's Olema Pharmaceuticals position peaked at $308K in Q2 2025.
  • 126 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q3 2025.

Based on Thrivent Financial for Lutherans's 13F filing for Q3 2025, filed 4 Nov 2025.